D. Niese

发表

Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies

A. Scherer, J. Walker, F. Raulf, 2003, Transplantation.

Pigeon breeder's lung: association with HLA-DR 3.

M. Baur, C. Rittner, D. Niese, 2008, Tissue antigens.

Heterosexual transmission of HIV in hemophiliacs

B. Kamps, H. Brackmann, K. Schneweis, 1990, Klinische Wochenschrift.

Graded cytopathogenicity of the human immunodeficiency virus (HIV) in the course of HIV infection

H. Brackmann, K. Schneweis, J. Kleim, 2004, Medical Microbiology and Immunology.

The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)

J. Reginster, O. Bruyère, R. Rizzoli, 2010, Osteoporosis International.

SLIM DISEASE (AIDS)

D. Niese, T. Kamradt, F. Vogel, 1985, The Lancet.

[Tuberculosis and atypical mycobacterioses in HIV infection. Results from the Bonn Center 1985 to 1989].

J. von Kempis, E. Musch, D. Niese, 1990, Medizinische Klinik.

Cold ischemia, histocompatibility, donor and recipient age: impact on early lymphocyte subsets and transplant outcome.

D. Paar, D. Niese, B. Klein, 1996, Transplantation proceedings.

Pigeon breeders’lung lacking detectable antibodies

C. Rittner, D. Niese, J. Sennekamp, 1978, Clinical allergy.

Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group.

P. Keown, D. Niese, Detlef Niese, 1998, Kidney international.

Cyclosporine microemulsion formulation (Neoral) in transplantation: pharmacokinetic/pharmacodynamic relationships.

E. Mueller, D. Niese, B. Mellein, 1998, Transplantation proceedings.

INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE THROMBOCYTOPENIA

A. Marmont, U. Budde, T. Jungi, 1983, The Lancet.

In Vivo Magnetic Resonance Techniques in Transplantation Research

D. Niese, 2006 .

HIV-1 infection in a cohort of haemophilic patients.

H. Brackmann, K. Schneweis, R. Bialek, 1990, Archives of disease in childhood.

Natural history of HIV-infection in hemophiliacs: Clinical, immunological, and virological findings

B. Kamps, H. Brackmann, K. Schneweis, 1989, Klinische Wochenschrift.

Incubation period of AIDS in haemophiliacs

B. Kamps, D. Niese, T. Kamradt, 1988, Nature.

Evidence for subtypic determinants in the HLA-DW3 cluster

N. Suciu-Foca, C. Rittner, H. Grosse-wilde, 1978, Human Genetics.

Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant patients receiving a microemulsion formulation.

J. Kovarik, P. Halloran, P. Keown, 1996, Transplantation.

Acute rejection relapses posttransplant: definition of risk group and evaluation of potent therapeutic regimens

D. Niese, H. Klehr, U. Jacobs, 1996 .

Acute rejection relapses posttransplant: definition of risk group and evaluation of potent therapeutic regimens.

D. Niese, H. Klehr, U. Jacobs, 1996, Transplant international : official journal of the European Society for Organ Transplantation.

RANDOMIZED, DOUBLE-BLIND, ONE-YEAR STUDY OF THE SAFETY AND TOLERABILITY OF CYCLOSPORINE MICROEMULSION COMPARED WITH CONVENTIONAL CYCLOSPORINE IN RENAL TRANSPLANT PATIENTS

H. Neumayer, B. Buchholz, U. Frei, 1998 .

Immunomodulating properties of the uremic pentapeptide H-Asp-Leu-Trp-Glu-Lys-OH in vitro

H. Dengler, S. Michels, D. Niese, 1986, Klinische Wochenschrift.

QEEG in Hemophiliacs with HIV Infection

P. Bülau, H. Brackmann, K. Alper, 1995, Clinical EEG.

Sandimmun neoral, a new oral formulation of cyclosporin A with improved pharmacokinetic characteristics: safety and tolerability in renal transplant patients.

E. Mueller, D. Niese, S. Taesch, 1994, Transplantation Proceedings.

Clinical development of a cyclosporine microemulsion in transplantation.

J. Kovarik, E. Mueller, D. Niese, 1996, Therapeutic Drug Monitoring.

Safety and tolerability of a new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patients

D. Niese, S. Taesch, 1994, Transplant international : official journal of the European Society for Organ Transplantation.

A European approach to clinical investigator training

B. Hirst, J. Boeynaems, C. Canivet, 2013, Front. Pharmacol..

A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months. The International Sandimmun Neoral Study Group.

D. Niese, 1995, Transplantation Proceedings.

Use of Sandimmun Neoral in renal transplant patients. International Sandimmun Neoral Study Group.

U. Frei, D. Niese, S. Taesch, 1994, Transplantation proceedings.

FcR‐mediated clearance in thrombopenic and non‐thrombopenic patients with hemophilia A and possible relation of thrombopenia to HIV seropositivity

H. Dengler, H. Brackmann, U. Budde, 1987, European Journal of Haematology.

Reticuloendothelial system Fc-receptor function in patients with immune thrombocytopenia after treatment with high dose intravenous immunoglobulin.

S. Reske, U. Budde, R. Schmidt, 2009, Scandinavian journal of haematology.

Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients. International Sandimmun Neoral Study Group.

H. Neumayer, B. Buchholz, U. Frei, 1998, Transplantation.

A double-blind randomized study of sandimmun neoral versus sandimmun in new renal transplant recipients : results after 12 months

D. Niese, 1995 .

China as a Growing Research Base for Innovation in Medicines Development

D. Niese, Michael E Humphries, Paul Dai, 2006, International Journal of Pharmaceutical Medicine.